Conestat alfa as prophylactic treatment for idiopathic non-histaminergic acquired angioedema Conestat alfa (Ruconest®).
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Conestat alfa (Primary)
- Indications Angioedema
- Focus Therapeutic Use
- Acronyms CAPI
- 20 Sep 2017 New trial record